Education
About Us
Working with TipRanks
Follow Us
Agilent (A)
NYSE:A
A Stock Chart & Stats
Day’s Range― - ―
52-Week Range$96.43 - $153.84
Previous CloseN/A
Volume231.77K
Average Volume (3M)1.70M
Market Cap
$34.98B
Enterprise Value$34.59B
Total Cash (Recent Filing)$1.53B
Total Debt (Recent Filing)$3.41B
Price to Earnings (P/E)28.6
Beta1.01
Next Earnings
Dec 01, 2025EPS Estimate
1.58Last Dividend Ex-Date
Sep 30, 2025Dividend Yield0.79%
Share Statistics
EPS (TTM)1.37
Shares Outstanding283,500,430
10 Day Avg. Volume1,624,625
30 Day Avg. Volume1,698,986
Financial Highlights & Ratios
PEG Ratio4.64
Price to Book (P/B)5.29
Price to Sales (P/S)4.79
P/FCF Ratio22.73
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue5.10
Enterprise Value/Gross Profit9.62
Enterprise Value/Ebitda19.25
Forecast
1Y Price Target
$140.82Price Target Upside14.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
Growth PotentialManagement is confident in double-digit growth for FY25 due to strong orders and progression in the replacement cycle.
Market PositionPharma & Biotech sectors showed strong growth, with customers gaining better access to budgets, aiding Agilent's performance.
Revenue PerformanceAgilent Technologies reported a top-line beat with revenues surpassing expectations, indicating strong demand and growth in sales.
Bears Say
Demand ChallengesA steep drop-off in U.S. demand for PFAS testing led to a significant decline in the Forensics & Environment segment.
Financial PerformanceThe company's operating margin was pressured by tariffs, which negatively impacted financial performance.
Margin PressureMargins missed expectations by 150 basis points due to tariffs, foreign exchange impacts, and investments.
Agilent News
A FAQ
What was Agilent’s price range in the past 12 months?
Agilent lowest stock price was $96.43 and its highest was $153.84 in the past 12 months.
What is Agilent’s market cap?
Agilent’s market cap is $34.98B.
When is Agilent’s upcoming earnings report date?
Agilent’s upcoming earnings report date is Dec 01, 2025 which is in 62 days.
How were Agilent’s earnings last quarter?
Agilent released its earnings results on Aug 27, 2025. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.368 by $0.002.
Is Agilent overvalued?
According to Wall Street analysts Agilent’s price is currently Undervalued.
Does Agilent pay dividends?
Agilent pays a Quarterly dividend of $0.248 which represents an annual dividend yield of 0.79%. See more information on Agilent dividends here
What is Agilent’s EPS estimate?
Agilent’s EPS estimate is 1.58.
How many shares outstanding does Agilent have?
Agilent has 283,500,430 shares outstanding.
What happened to Agilent’s price movement after its last earnings report?
Agilent reported an EPS of $1.37 in its last earnings report, beating expectations of $1.368. Following the earnings report the stock price went up 5.283%.
Which hedge fund is a major shareholder of Agilent?
Currently, no hedge funds are holding shares in A
Agilent Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$140.82 (14.13% Upside)
$140.82 (14.13% Upside)
Blogger Sentiment
Bullish
A Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 59.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.26%
12-Months-Change
Fundamentals
Return on Equity
19.88%
Trailing 12-Months
Asset Growth
11.19%
Trailing 12-Months
Company Description
Agilent
Agilent Technologies, Inc. (A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for laboratories in a variety of sectors, including pharmaceuticals, biotechnology, environmental, and food safety industries. Agilent's core products include analytical instruments, such as gas and liquid chromatography systems, mass spectrometry, and spectroscopy equipment, as well as molecular biology tools and solutions that support genomics and proteomics research.
A Company Deck
A Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a strong performance with revenue and growth exceeding expectations, driven by significant gains in key markets and regions. However, pressures from tariffs and margin challenges, along with specific market declines, balanced the positive aspects.View all A earnings summariesA Revenue Breakdown
49.39% Life Sciences and Applied Markets
25.36% Diagnostics and genomics
25.25% Agilent CrossLab
A Stock 12 Month Forecast
Average Price Target
$140.82
▲(14.13% Upside)
Technical Analysis
Ownership Overview
0.26% Insiders
27.26% Mutual Funds
21.69% Other Institutional Investors
24.87% Public Companies and Individual Investors